Eli Lilly Eyeing More R&D Pacts in India (India)
This article was originally published in PharmAsia News
Executive Summary
Eli Lilly plans to increase its research and development (R&D) outsourcing in India this year and sign a few more agreements with Indian pharmaceutical companies as a way to cut drug development costs. Eli Lilly signed contracting deals with Mumbai-based Nicholas Piramal in January this year and Hyderabad-based Suven Life Sciences in August 2006. Eli Lilly India managing director Sandeep Gupta says any outsourcing decisions are being made at Eli Lilly's global headquarters. (Click here for more
You may also be interested in...
Lilly's Chorus Experiment
With clinical failure rates rising industry-wide, a skunkworks at Lilly, called Chorus, has been trying to boost likely-to-succeed shots on goal by getting compounds to human proof-of-concept far faster and cheaper than the internal organization. Lilly's R&D group is skeptical about the program, even anxious -- one reason Chorus has teamed up with a major venture fund to get more molecules to test. If the program works, will Lilly embrace it - or will its venture partner reap the rewards?
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.